Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies

von Tresckow, Bastian; Sayehli, Cyrus; Aulitzky, Walter E.; Goebeler, Maria-Elisabeth; Schwab, Matthias; Braz, Eunice; Krauss, Babett; Krauss, Rolf; Hermann, Frank; Bartz, Rene; Engert, Andreas

dc.contributor.author	Schwab, Matthias
dc.date.accessioned	2020-06-30T11:26:57Z
dc.date.available	2020-06-30T11:26:57Z
dc.date.issued	2019
dc.identifier.issn	1600-0609
dc.identifier.uri	http://hdl.handle.net/10900/102003
dc.language.iso	en	de_DE
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/ejh.13188	de_DE
dc.subject.ddc	610	de_DE
dc.title	Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_02899
utue.publikation.seiten	163-173	de_DE
utue.personen.roh	von Tresckow, Bastian
utue.personen.roh	Sayehli, Cyrus
utue.personen.roh	Aulitzky, Walter E.
utue.personen.roh	Goebeler, Maria-Elisabeth
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Braz, Eunice
utue.personen.roh	Krauss, Babett
utue.personen.roh	Krauss, Rolf
utue.personen.roh	Hermann, Frank
utue.personen.roh	Bartz, Rene
utue.personen.roh	Engert, Andreas
dcterms.isPartOf.ZSTitelID	European Journal of Haematology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	102	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE